Corteva completes spin‑off of seed business, creating independent Vylor
+3 new sources since this summary was written
On October 1 2026 Corteva finished separating its seed and genetics unit into a new publicly traded company, Vylor. The split leaves Corteva as a pure‑play crop‑protection firm with an $11 billion pipeline and a reported revenue increase of more than $1 billion from 2020 to 2025. Analysts quickly revised their valuations, setting new price targets for the “new Corteva” between $17 and $20 and upgrading several ratings.
Why it matters
The spin‑off resets Corteva’s valuation, prompting analysts to lower price targets (e.g., Goldman Sachs to $20, RBC to $17) and upgrade ratings, which will affect investor expectations and trading activity. The company also expects a stronger focus on crop‑protection growth and margin expansion.
Key facts
- 1The spin‑off of Corteva’s seed business became effective on October 1 2026, creating the independent company Vylor. millingmea.com
- 2Corteva reported revenue growth of over $1 billion and a 250‑basis‑point margin expansion from 2020 to 2025. proagri.co.za
- 3The company highlighted an $11 billion pipeline of new active ingredients. farmersguide.co.uk
- 4KeyBanc set a $17 price target for Corteva and upgraded the rating to Overweight. tradingview.com
- 5Goldman Sachs lowered its price target to $20 from $96 and kept a Buy rating. investing.com
- 6RBC Capital cut its price target to $17 from $103, citing the spin‑off. investing.com
Summary written by AlphAI AI Desk from 12 of 12 sources. Not investment advice. Figures are as stated by the linked sources.